Nancy, lead biotech analyst, joined the firm in August 2022. Nancy previously worked as a senior associate with Jefferies LLC, assisting senior analysts in the coverage of development-stage biotech companies. She earned her Ph.D. in Chemistry from Stanford University and a B.S. in Chemistry from the University of Southern California. Nancy has 1 year of investment research experience and over 8 years’ experience in chemical biology, gene therapy, polymer chemistry, medicinal chemistry, data analysis, biotechnology project management, and the drug development process. Nancy has 9 years’ experience including her post-doctoral.